Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Wakefulness: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Josikins
adding citations
>Graham
m Category change
 
(19 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<onlyinclude>
<onlyinclude>
'''Wakefulness''' is an increased ability to stay conscious without feeling sleepy combined with a decreased need to sleep.<ref>Wakefulness Definition | http://www.dictionary.com/browse/wakefulness</REF> It is contrasted with [[stimulation]] in that it does not directly increase one's energy levels above a normal baseline but instead produces feelings of a wakeful, well-rested, and alert state. If one is sleepy before using this substance, the impulse to sleep will fade, keeping one’s eyes open will become easier, and the cognitive fog of exhaustion will be reduced.<ref>A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study (ncbi) | https://www.ncbi.nlm.nih.gov/pubmed/10923755</ref> However, sufficiently accumulated sleep deficiency can overpower or negate this effect in extreme cases.
'''Wakefulness''' is defined as an increased ability to stay conscious without feeling sleepy combined with a decreased need to sleep.<ref name="Porkka-Heiskanen1997">{{cite journal|last1=Porkka-Heiskanen|first1=T.|title=Adenosine: A Mediator of the Sleep-Inducing Effects of Prolonged Wakefulness|journal=Science|volume=276|issue=5316|year=1997|pages=1265–1268|issn=00368075|doi=10.1126/science.276.5316.1265}}</ref> It is contrasted with [[stimulation]] in that it does not directly increase one's energy levels above a normal baseline but instead produces feelings of a wakeful, well-rested, and alert state.<ref name="RepantisSchlattmann2010">{{cite journal|last1=Repantis|first1=Dimitris|last2=Schlattmann|first2=Peter|last3=Laisney|first3=Oona|last4=Heuser|first4=Isabella|title=Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review|journal=Pharmacological Research|volume=62|issue=3|year=2010|pages=187–206|issn=10436618|doi=10.1016/j.phrs.2010.04.002}}</ref><ref name="EngberDennis1998">{{cite journal|last1=Engber|first1=T.M|last2=Dennis|first2=S.A|last3=Jones|first3=B.E|last4=Miller|first4=M.S|last5=Contreras|first5=P.C|title=Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine|journal=Neuroscience|volume=87|issue=4|year=1998|pages=905–911|issn=03064522|doi=10.1016/S0306-4522(98)00015-3}}</ref> If one is sleepy before using this substance, the impulse to sleep will fade, keeping one’s eyes open will become easier, and the cognitive fog of exhaustion will be reduced.<ref name="CaldwellCaldwell2000">{{cite journal|last1=Caldwell|first1=John A.|last2=Caldwell|first2=J. Lyn|last3=Smyth|first3=Nicholas K.|last4=Hall|first4=Kecia K.|title=A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study|journal=Psychopharmacology|volume=150|issue=3|year=2000|pages=272–282|issn=0033-3158|doi=10.1007/s002130000450}}</ref> However, sufficiently accumulated sleep deficiency can overpower or negate this effect in extreme cases.<ref name="RepantisSchlattmann2010" />


Wakefulness is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of a wide variety of compounds such as [[stimulant|stimulants]], [[nootropic|nootropics]], and [[psychedelic|psychedelics]]. However, it is worth noting that the few compounds which selectively induce this effect without a number of other accompanying effects are referred to as [[eugeroic]]s or wakefulness-promoting agents. These include [[modafinil]],<ref>FDA Provigil Prescription Guidelines | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020717s037s038lbl.pdf</ref> [[armodafinil]],<ref>FDA Nuvigil Prescription Guidelines | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021875s021lbledt.pdf</ref> and [[Noopept]].  
Wakefulness is most commonly induced under the influence of [[dosage#common|moderate]] [[dosage|dosages]] of a wide variety of compounds such as [[stimulant|stimulants]], [[nootropic|nootropics]], and [[psychedelic|psychedelics]]. However, it is worth noting that the few compounds which selectively induce this effect without a number of other accompanying effects are referred to as [[eugeroic]]s or wakefulness-promoting agents. These include [[modafinil]]<ref name="RepantisSchlattmann2010" /><ref name="EngberDennis1998" /><ref name="MyrickMalcolm2004">{{cite journal|last1=Myrick|first1=Hugh|last2=Malcolm|first2=Robert|last3=Taylor|first3=Brent|last4=LaROWE|first4=STEVEN|title=Modafinil: Preclinical, Clinical, and Post-Marketing Surveillance—A Review of Abuse Liability Issues|journal=Annals of Clinical Psychiatry|volume=16|issue=2|year=2004|pages=101–109|issn=10401237|doi=10.1080/10401230490453743}}</ref><ref name="ScammellEstabrooke2000">{{cite journal|last1=Scammell|first1=Thomas E.|last2=Estabrooke|first2=Ivy V.|last3=McCarthy|first3=Marie T.|last4=Chemelli|first4=Richard M.|last5=Yanagisawa|first5=Masashi|last6=Miller|first6=Matthew S.|last7=Saper|first7=Clifford B.|title=Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness|journal=The Journal of Neuroscience|volume=20|issue=22|year=2000|pages=8620–8628|issn=0270-6474|doi=10.1523/JNEUROSCI.20-22-08620.2000}}</ref> and [[armodafinil]].<ref name="RepantisSchlattmann2010" />
</onlyinclude>
</onlyinclude>
===Psychoactive substances===
===Psychoactive substances===
Line 18: Line 18:
* [https://en.wikipedia.org/wiki/Wakefulness Wakefulness (Wikipedia)]
* [https://en.wikipedia.org/wiki/Wakefulness Wakefulness (Wikipedia)]
===References===
===References===
<references/>
<references />
[[Category:Cognitive]] [[Category:Enhancement]] [[Category:Effect]]
[[Category:Cognitive]]  
[[Category:Intensification]]  
[[Category:Effect]]

Latest revision as of 19:56, 4 October 2022

Wakefulness is defined as an increased ability to stay conscious without feeling sleepy combined with a decreased need to sleep.[1] It is contrasted with stimulation in that it does not directly increase one's energy levels above a normal baseline but instead produces feelings of a wakeful, well-rested, and alert state.[2][3] If one is sleepy before using this substance, the impulse to sleep will fade, keeping one’s eyes open will become easier, and the cognitive fog of exhaustion will be reduced.[4] However, sufficiently accumulated sleep deficiency can overpower or negate this effect in extreme cases.[2]

Wakefulness is most commonly induced under the influence of moderate dosages of a wide variety of compounds such as stimulants, nootropics, and psychedelics. However, it is worth noting that the few compounds which selectively induce this effect without a number of other accompanying effects are referred to as eugeroics or wakefulness-promoting agents. These include modafinil[2][3][5][6] and armodafinil.[2]

Psychoactive substances

... further results

Experience reports

Anecdotal reports which describe this effect within our experience index include:

See also

References

  1. Porkka-Heiskanen, T. (1997). "Adenosine: A Mediator of the Sleep-Inducing Effects of Prolonged Wakefulness". Science. 276 (5316): 1265–1268. doi:10.1126/science.276.5316.1265. ISSN 0036-8075. 
  2. 2.0 2.1 2.2 2.3 Repantis, Dimitris; Schlattmann, Peter; Laisney, Oona; Heuser, Isabella (2010). "Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review". Pharmacological Research. 62 (3): 187–206. doi:10.1016/j.phrs.2010.04.002. ISSN 1043-6618. 
  3. 3.0 3.1 Engber, T.M; Dennis, S.A; Jones, B.E; Miller, M.S; Contreras, P.C (1998). "Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine". Neuroscience. 87 (4): 905–911. doi:10.1016/S0306-4522(98)00015-3. ISSN 0306-4522. 
  4. Caldwell, John A.; Caldwell, J. Lyn; Smyth, Nicholas K.; Hall, Kecia K. (2000). "A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study". Psychopharmacology. 150 (3): 272–282. doi:10.1007/s002130000450. ISSN 0033-3158. 
  5. Myrick, Hugh; Malcolm, Robert; Taylor, Brent; LaROWE, STEVEN (2004). "Modafinil: Preclinical, Clinical, and Post-Marketing Surveillance—A Review of Abuse Liability Issues". Annals of Clinical Psychiatry. 16 (2): 101–109. doi:10.1080/10401230490453743. ISSN 1040-1237. 
  6. Scammell, Thomas E.; Estabrooke, Ivy V.; McCarthy, Marie T.; Chemelli, Richard M.; Yanagisawa, Masashi; Miller, Matthew S.; Saper, Clifford B. (2000). "Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness". The Journal of Neuroscience. 20 (22): 8620–8628. doi:10.1523/JNEUROSCI.20-22-08620.2000. ISSN 0270-6474.